MedPath

Comparing a targeted biopsy regimen with a targeted and surveillance (Seattle protocol) biopsy regimen in eradicated dysplastic Barrett's oesophagus: a prospective study

Not Applicable
Completed
Conditions
Barrett's oesophagus
Oesophageal adenocarcinoma
Oral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon
Cancer - Oesophageal (gullet)
Registration Number
ACTRN12618001198213
Lead Sponsor
Princess Alexandra Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
121
Inclusion Criteria

Adult patients who have undergone successful Barrett's oesophagus eradication who are currently having follow-up surveillance endoscopies

Exclusion Criteria

patients with dysplastic Barrett's that have not achieved complete eradication of intestinal metaplasia.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Proportion of abnormal biopsies (findings other than neo-squamous epithelium; ie. intestinal metaplasia) found on targeted and surveillance biopsies as per Seattle protocol during upper endoscopy in previously eradicated dysplastic Barrett's oesophagus[At time of upper endoscopy]
Secondary Outcome Measures
NameTimeMethod
Time involved with obtaining endoscopic surveillance biopsies as per Seattle protocol. This will be measured using stopwatch timers. [At time of upper endoscopy];Cost involved with obtaining endoscopic surveillance biopsies as per Seattle protocol. The Seattle protocol biopsies are placed in a new specimen pot for each centimetre. The costs for the histological assessment are clearly defined for a single pot of biopsies therefore allowing an exact cost calculation. The costs will be obtained from the Pathology Queensland website (http://hsqapps.hsq.health.qld.gov.au/testlistPQ/default.aspx), which have the cost of various investigations available.[At time of upper endoscopy]
© Copyright 2025. All Rights Reserved by MedPath